ClinicalTrials.gov
ClinicalTrials.gov Menu

Gemcitabine for Marginal Zone Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00337259
Recruitment Status : Terminated (poor accrual and response less than expected on interim analysis)
First Posted : June 15, 2006
Last Update Posted : February 17, 2016
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Cheolwon Suh, Asan Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2009
  Actual Study Completion Date : March 2009